biotech insider buys Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : biotech insider buys

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Icebrg who wrote (124)	11/17/2005 2:07:21 PM
From: ejgopher	Read Replies (1) of 213

Insiders buys are a bait. The reality is that TTP is in a death spiral with toxic financing from Cornell Capital Partners. $35M over 2 yrs deal, $2M trances 6 days prior notice (opportunity to short), the Company will issue to Cornell a number of shares of its common shares equal to the amount of the draw-down divided by the lowest daily volume weighted average price of the Company’s common shares during the five trading days following the draw-down notice to Cornell, 5% commission, $500 to Yorkville ... When this thing is over, TTP will never see $35M cash since Cornell will have owned just under 10% of the common shares due to massive dilution. secfilings.nasdaq.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next